- امروز : یکشنبه, ۱۸ شهریور , ۱۴۰۳
- برابر با : Sunday - 8 September - 2024
اخبار ویژه
Looking for Weight Loss? Go Nuts
Robust Gut Microbiome Can Help You Fight Infections
GLP-1 Medicine Mounjaro May Be First Drug to Ease Sleep Apnea
Plane Hygiene: Staying Healthy at 35,000 Feet
Dad Facts: What Men Need to Know About Their Fertility
۱ in 4 U.S. Yards May Have Unsafe Levels of Lead
Modifying Homes for Stroke Survivors Helps Them Stay Independent
New Hope for People With Aggressive Form of Lymphoma
Mounjaro (tirzepatide)
GLP-1 Medicine Mounjaro May Be First Drug to Ease Sleep Apnea
A medication used to manage type 2 diabetes has been found effective in treating sleep apnea.
WHO, Lilly Issue Warnings About Fake Weight-Loss Drugs
Both the World Health Organization and Eli Lilly warned Thursday that consumers should avoid fake versions of weight-loss drugs that are circulating in numerous countries.
Experimental GLP-1 Med Might Be Breakthrough Against Fatty Liver Disease
An experimental 'supercharged' form of popular GLP-1 weight-loss meds could help ease fatty liver disease, a new trial suggests.
Wegovy, Ozempic May Help Curb Alcohol Dependence
Could the blockbuster GLP-1 meds like Wegovy and Ozempic have a role to play in helping people cut down on problem drinking? A new study suggests so.
GLP-1 Weight Loss Meds Might Keep Your Pancreas Healthy
Ozempic and Wegovy might help lower the risk of pancreatitis in patients with obesity and type 2 diabetes, a new study says.
Could New Weight-Loss Drugs Be Changing Women’s Taste for Sweets?
Ozempic and Wegovy appear to improve people’s sensitivity to tastes, potentially lowering their desire for sweets, a new study suggests.
Costs, Side Effects Drive Folks to Quit New Weight-Loss Meds
Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from first use more than a third have stopped, new research shows.
Use of GLP-1 Meds Have Risen 7-Fold Among Young Americans
The number of American teens and young adults who've been prescribed one of the new GLP-1 weight-loss drugs soared nearly seven-fold between 2020 and 2023, a new report finds.
Looking for Weight Loss? Go Nuts
Robust Gut Microbiome Can Help You Fight Infections
